Puzo Michael J Sells 2,300 Shares of Xylem Inc (XYL)

Puzo Michael J decreased its holdings in Xylem Inc (NYSE:XYL) by 5.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,910 shares of the industrial products company’s stock after selling 2,300 shares during the period. Puzo Michael J’s holdings in Xylem were worth $2,555,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of XYL. Congress Asset Management Co. MA increased its stake in shares of Xylem by 4,780.9% in the second quarter. Congress Asset Management Co. MA now owns 1,112,856 shares of the industrial products company’s stock worth $74,984,000 after purchasing an additional 1,090,056 shares in the last quarter. USS Investment Management Ltd increased its stake in shares of Xylem by 43.7% in the second quarter. USS Investment Management Ltd now owns 2,615,320 shares of the industrial products company’s stock worth $176,220,000 after purchasing an additional 795,628 shares in the last quarter. Stifel Financial Corp increased its stake in shares of Xylem by 2,129.0% in the first quarter. Stifel Financial Corp now owns 249,268 shares of the industrial products company’s stock worth $19,173,000 after purchasing an additional 238,085 shares in the last quarter. Carillon Tower Advisers Inc. purchased a new position in shares of Xylem in the first quarter worth about $14,849,000. Finally, Handelsbanken Fonder AB increased its stake in shares of Xylem by 24.2% in the first quarter. Handelsbanken Fonder AB now owns 876,965 shares of the industrial products company’s stock worth $67,456,000 after purchasing an additional 170,965 shares in the last quarter. Hedge funds and other institutional investors own 83.37% of the company’s stock.

Shares of Xylem traded down $0.15, reaching $70.04, during trading hours on Monday, Marketbeat Ratings reports. The stock had a trading volume of 127,837 shares, compared to its average volume of 1,040,596. The company has a current ratio of 1.42, a quick ratio of 1.02 and a debt-to-equity ratio of 0.87. Xylem Inc has a 12 month low of $56.54 and a 12 month high of $79.83. The firm has a market capitalization of $12.63 billion, a P/E ratio of 29.28, a price-to-earnings-growth ratio of 1.35 and a beta of 1.09.



Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, May 1st. The industrial products company reported $0.51 EPS for the quarter, meeting analysts’ consensus estimates of $0.51. Xylem had a net margin of 7.29% and a return on equity of 18.31%. The company had revenue of $1.22 billion during the quarter, compared to analyst estimates of $1.19 billion. During the same period last year, the business earned $0.39 earnings per share. Xylem’s revenue was up 13.6% compared to the same quarter last year. sell-side analysts predict that Xylem Inc will post 2.89 EPS for the current year.

In other news, Director Curtis J. Crawford sold 7,500 shares of the firm’s stock in a transaction that occurred on Monday, May 14th. The shares were sold at an average price of $73.39, for a total value of $550,425.00. Following the completion of the transaction, the director now directly owns 41,744 shares in the company, valued at $3,063,592.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.81% of the stock is currently owned by company insiders.

XYL has been the subject of several recent research reports. Zacks Investment Research downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research note on Monday, April 9th. Oppenheimer restated a “buy” rating and issued a $82.00 price objective on shares of Xylem in a research report on Tuesday, May 1st. Boenning Scattergood restated a “buy” rating and issued a $90.00 price objective on shares of Xylem in a research report on Tuesday, May 1st. Canaccord Genuity set a $78.00 price objective on shares of Xylem and gave the company a “hold” rating in a research report on Tuesday, April 24th. Finally, BMO Capital Markets cut their price objective on shares of Xylem from $86.00 to $83.00 and set an “outperform” rating for the company in a research report on Wednesday, May 2nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and seven have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $80.20.

Xylem Profile

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Read More: Stock Ratings and Recommendations: Understanding Analyst Upgrades and Downgrades

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply